8. Emergining and re-emergining infectious diseases
9. Hospital acquired infections
10
Communicable Diseases
4. Respiratory infections
SMALLPOX (VARIOLA)
CHICKENPOX (VARICELLA)
MEASLES (RUBEOLA)
Challenges for Measles elimination
Weak immunization systems
High infectious nature of measles
Inaccessible populations due to conflict
Increased immunization refusal group of people
Changing epidemiology of measles
•
This has led to increased transmission among adolescents and adults
Need to provide catch-up measles vaccination
Gaps in human and financial resources at the country, regional and global levels
Epidemiological determinants
Agent factors
▢ Agents: RNA paramyxovirus
▢ Source of infection:
Only source of infection is Case of measles
No carriers
▢ Infective material:
Secretions of the nose, throat and respiratory tract of a case of measles.
▢ Communicability: 4 days before and 4 days after the appearance of the rash
▢ Secondary attack rate:
Host factors
▢ Age:
❖ Developing country: 6 months and 3 years of age
❖ Developed country: Over 5 years
▢ Sex: Equal incidence
▢ Immunity: Life-long immunity by 1st attack.
▢ Nutrition:
•
Severe in malnourished child (400 times higher than well-nourished child)
Environmental factors
Transmission
Incubation period
▢ From exposure to onset of fever: 10 days
▢ From exposure to onset of rash: 14 days
▢ Artificially induced bypassing the respiratory tract (as with injection of live measles vaccine): 7 days
Clinical factors
Prodromal stage
▢ Timing:
Between fever and rash
Begins 10 days after infection and lasts until day 14
▢ Characteristic:
❖ Fever:
❖ Coryza with sneezing and nasal discharge:
❖ Cough:
❖ Redness of eyes:
❖ Lacrimation and often photophobia:
❖ Vomiting or Diarrhoea:
❖ Koplik's spots:
It is like table salt crystals.
They are small, bluish-white spots on a red base, smaller than the head of a pin.
It is present on the buccal mucosa opposite the first and second lower molars.
It appears 1 or 2 days before the appearance of the rash.
It is pathognomonic of measles.
Eruptive stage
This phase is characterized by the appearance of Rash.
▢ Rash:
The rash is typical, dusky-red, macular or maculo-papular.
It begins behind the ears and spreads rapidly in a few hours over the face and neck, and extends down the body taking 2 to 3 days to progress to the lower extremities.
They may remain discrete, but often becomes confluent and blotchy.
The lesions and fever disappear in another 3 or 4 days signalling the end of the disease.
The rash fades in the same order of appearance leaving a brownish discoloration which may persist for 2 months or more.
The rash develops as the interaction of immune T cells with virus-infected cells in the small blood vessels. Hence no rash develops in patient with defective cell-mediated immunity.
▢ Antigen-antibody:
The virus is present in tears, nasal and throat secretions, urine and blood in the prodromal and eruptive stage.
Just as the maculo-papular rash appears, the circulating antibodies become detectable, the viraemia disappears and the fever falls.
Post-measles stage
It is the resolving stage.
Weight-loss
Weakness for a number of days
Failure to recover and a gradual deterioration into chronic illness
Growth retardation and Diarrhoea
Cancrum oris
Pyogenic infections
Candidosis
Reactivation of pulmonary tuberculosis
Complications
▢ Common complications:
Otitis media
Laryngotracheo-bronchitis (croup)
Diarrhoea and Dehydration
Pneumonia
Post-infectious measles encephalitis
Sub-acute sclerosing panencephalitis (SSPE)
▢ Measles during pregnancy:
It is not known to cause any congenital abnormalities of the foetus.
However, it is associated with spontaneous abortion and premature delivery.
Diagnosis
▢ Clinical diagnosis:
It is detected clinically based on typical rash and Koplik's spots seen in oral mucosa.
▢ Molecular methods:
Detection of specific IgM antibodies by ELISA
Detection of measles virus RNA by RT-PCR in throat swabs, oral fluids or nasopharyngeal mucus or urine.
Treatment
No specific treatment for measles
▢ Supportive care:
Relieving common symptoms such as
Fever
Cough
Nasal congestion or Rhinorrhea
Conjunctivitis
Sore mouth
▢ Nutritional support: Reduces the risk of malnutrition due to diarrhoea, vomiting and poor appetite associated with measles.
▢ Breast-feeding: Should be encouraged.
▢ Oral rehydration salts: It prevents dehydration.